The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy

Journal of Gastrointestinal Surgery

Volumn 19, Issue 9, 2015, Pages 1676-1683

  Manyam, Bindu V ^a   Mallick, Ismail H ^a   Abdel Wahab, May M ^a   Reddy, Chandana A ^a   Remzi, Feza H ^a   Kalady, Matthew F ^a   Lavery, Ian ^a   Koyfman, Shlomo A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Locoregional recurrence; Oligometastatic rectal cancer; Radical primary resection; Radiotherapy

Indexed keywords

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; AGED; CANCER STAGING; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREVENTION AND CONTROL; RECTAL NEOPLASMS; RETROSPECTIVE STUDY; SECONDARY; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84939473885     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-015-2861-9     Document Type: Article

References (23)

1. National Comprehensive Cancer Network: Practice guidelines in oncology. Rectal cancer. www.nccn.org, v.4, 2013.
2. Venderbosch S, deWilt JH, Teerenstra S, et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol 2011; 18:3253-3260.
3. Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197:233-242.
4. Millikian KW, Staren ED, Doolas A. Invasive therapy of metastatic colorectal cancer to the liver. Surg Clin North Am 1997; 77:27-48.
5. An HJ, Yu CS, Yun SC, et al. Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence. Int J Radiation Oncol Biol Phys 2012; 84:73-80.
6. Koopman M, Antonini NF, Douma J, et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxliplatin in advanced colorectal cancer (CAIRO): a phase III randomized controlled trial. Lancet 2007; 370:135-142.
7. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2013; 30:1926-1933.
8. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993; 36:564-672.
9. Butte JM, Gonen M, Ding P, et al. Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer 2012; 118:5414-5423.
10. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009; 27:3379-3384.
11. Cellini C, Hunt SR, Fleshman JW, et al. Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor? World J Surg 2010; 34:1102-1108.
12. Rees M, Tekkis P, Welsh F, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247:125-135.
13. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818-827.
14. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244:254-259.
15. Chang CY, Kim HC, Park YS, et al. The effect of postoperative pelvic irradiation after complete resection of metastatic rectal cancer. J Surg Oncol 2012; 105:244-248.
16. Kim JW, Kim YB, Kim N, et al. The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study. Radiat Oncol 2010; 5:75-81.
17. Thomas PR, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 1998; 13:245-252.
18. Mohiuddin M, Winter K, Mitchell E, et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006; 4:650-655.
19. Minsky BD, Cohen AM, Kemeny N, et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992; 10:1218-1224.
20. Turner II, Russell GB, Blackstock AW, et al. Impact of neoadjuvant therapy on postoperative complications in patients undergoing resection for rectal adenocarcinoma. Am Surg 2004; 70:1045-1049.
21. Schiffman L, Wedermann N, Gock N, et al. Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications. BMC Surg 2013; 13:43-48.
22. Law WL, Chu KW. Outcomes of resection of stage IV rectal cancer with mesorectal excision. Outcomes of resection of stage IV rectal cancer with mesorectal excision. J Surg Onc 2006; 93:523-538.
23. Assumpcoa L, Choti MA, Gleismer AL, et al. Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site. Arch Surg 2008; 143:743-749.